GlaxoSmithKline Opens $600million Vaccine Plant In...(hospitals. Leveraging Singapore's str...),Health
Navigation Links
GlaxoSmithKline Opens $600million Vaccine Plant In Singapore
Date:6/16/2009
hospitals.
Leveraging Singapore's strong scientific and economic fundamentals, global biomedical sciences companies invested more than $500 million here in the year 2008 alone. A growing base of more than 50 global pharmaceutical, biotechnology and medical technology companies are carrying out R&D in Singapore, alongside 30 public-sector research and medical institutes. Amongst them, more than 10 leading multi-national companies have established their regional headquarters in Singapore. They include AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Merck, Quintiles and Sanofi-Aventis. Their continued confidence is testament to Singapore's position as a leading global manufacturing site for innovative medicines.
To find out more about working and living in Singapore, log on to Contact Singapore's website at www.contactsingapore.sg or search for jobs at www.contactsingapore.sg/jobs.
For more information about Singapore's biomedical sciences sector, log on to the Singapore Economic Development Board's website at http://www.edb.gov.sg/edb/sg/en_uk/index/industry_sectors/pharmaceuticals__/industry_background.html and the Agency for Science, Technology and Research's website at http://www.a-star.edu.sg.
About Contact Singapore
Contact Singapore is an alliance of the Singapore Economic Development Board and Ministry of Manpower. It aims to attract global talent to work, invest and live in Singapore.
With offices in Asia Paci
'/>"/>
| Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved |
Related medicine news :
1. GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
2. GlaxoSmithKline Travel Health: 55 percent of travellers needlessly put themselves at risk from a potentially fatal virus
3. Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
4. GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
5. GlaxoSmithKline Update: Influenza A (H1N1)
6. GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
7. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
8. IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2009 Innovation in Oral Care Awards
9. GlaxoSmithKline Consumer Healthcare to Reach 85 Percent of the Worlds Smokers with Quit Aids
10. GlaxoSmithKline Consumer Healthcare Helps to Bridge Oral Care Gap in Appalachia
11. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
Post Your Comments:
Related Image:
 GlaxoSmithKline Opens $600million Vaccine Plant In Singapore |
(Date:11/20/2009)... supply, study finds , , FRIDAY, Nov. 20...f prescription drugs is up to one-third cheaper th...tudy. , U.S. researchers analyzed 26,852 prescr..., and found that patients who bought a three-month...rage 29 percent in out-of-pocket costs. After the ...
(Date:11/20/2009)...ed to continue, CDC says, , , FRIDAY, N...d States are seeing declines in H1N1 swine flu act...while the disease remains widespread in 43 states,.... , "We are beginning to see some declines in i... still a lot of influenza everywhere," Dr. Anne Sc...
(Date:11/20/2009)...ased food insecurity as many face problem of hunge...- Project Bread, the state,s leading anti-hunger o...nual status report on hunger in the Commonwealth. ...aused by high unemployment, point to 554,000 peopl... insecurity has found its way into middle class su...
(Date:11/20/2009)... Omnicell, Inc. (Nasdaq:... acute healthcare facilities, announced today the ...fray Healthcare Conference at the New York Palace... Randall A. Lipps, founder, chairman, president &a..., Date: Tuesday, December 1, 2009 ,, Time: ...
(Date:11/20/2009)...wswire-USNewswire/ -- The Louisiana Association ...ans could experience higher health care premiums a...by Congress should become law. ,, According to ...siana health plans have supported comprehensive he...al debate. Our plans have offered significant cha...
Breaking Medicine News(10 mins):Health News:Three-Month Supply Lowers Drug Costs 2Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2[0] Three-Month Supply Lowers Drug Costs[0] Swine Flu Declining in Some Parts of U.S.[0] 554,000 in Massachusetts Struggle to Put Food on the Table[0] Omnicell to Present at Piper Jaffray Healthcare Conference[0] Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians
...shows amount in outer hair cell membranes affects ...ount of cholesterol in the outer hair cell membran... study concludes. , "We,ve known for a long time t...ing," senior author Dr. William Brownell, a profes...
...ars of follow-up, older women taking the newer dru...c. 14 (HealthDay News) -- The aromatase inhibitor ...d tamoxifen when it comes to preventing recurrence... a benefit, researchers said. , "It has been very...
...ber 14, 2007 A new review article from the journa...rug used to treat lymphoma, is now becoming used b...iseases. , Originally developed as the standard ...n dermatology and found that it successfully treat...
...c. 14 Veridex, LLC, a,Johnson & Johnson company, ...d the GeneSearch(TM) Breast Lymph Node (BLN) Assay..., In the December 24th issue of the magazine, ava... say, "doctors can,accurately test the sentinel no...
...ec. 14 The 10th Annual Customer,Experience Confer...ience,",sponsored by Best Practices, LLC,s Global ...ton Hotel in Phoenix, Ariz., Feb. 25-27, 2008. Thi...tition., Download "Using Quality to Improve the C...
... Combines Personal Responsibility and Public,Dolla...tt today announced the approval of a Medicaid waiv...nt an innovative health care proposal giving,appro...g applications for the new health care coverage, c...
Other Medicine News:Health News:Study Finds Cholesterol Fine-Tunes Hearing 2Health News:Arimidex Beats Tamoxifen in Keeping Breast Cancer at Bay 2Health News:Arimidex Beats Tamoxifen in Keeping Breast Cancer at Bay 3Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 2Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 3Health News:TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007 4Health News:Reserve 2008 Budget for Using Quality to Improve the Customer Experience 2Health News:HHS Approves Medicaid Waiver to Create New Indiana Health Plan for Uninsured Hoosiers 2Study Finds Cholesterol Fine-Tunes HearingArimidex Beats Tamoxifen in Keeping Breast Cancer at BayLymphoma drug used to treat skin disordersTIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007Reserve 2008 Budget for Using Quality to Improve the Customer ExperienceHHS Approves Medicaid Waiver to Create New Indiana Health Plan for Uninsured Hoosiers
(Date:11/20/2009)...swire/ -- Reportlinker.com announces that a new ma.... ,, Pipettes & Pipettors - A Global Marke.../p0164373/Pipettes--Pipettors---A-Global-Market-Pe...m=pr&utm_campaign=prnewswire ,, Pipettes ...ny research laboratory. Large-scale applications i...
(Date:11/20/2009)...ov. 20 Boston Scientific...t has received 510(k) clearance from the U.S. Food...l to market its WallFlex® Fully Covered Esoph...eal strictures (obstructions) caused by tumors in ...eal cancer. ,, (Photo: http://www.newscom.co...
(Date:11/20/2009)...ewswire-FirstCall/ -- Smith & Nephew ( SNN, LS...e the signing of a technology development contract... may lead to the creation of a fracture fixation s...he limbs of soldiers who sustain battlefield injur...h Projects Agency (DARPA), the central research an...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 56087 1ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 56087 2Chindex International Announces September Investor Conferences Participation 56083 1Chindex International Announces September Investor Conferences Participation 56083 2Abbott to Acquire Visiogen Expanding Vision Care Portfolio 56078 1Abbott to Acquire Visiogen Expanding Vision Care Portfolio 56078 2Abbott to Acquire Visiogen Expanding Vision Care Portfolio 56078 3Abbott to Acquire Visiogen Expanding Vision Care Portfolio 56078 4Abbott to Acquire Visiogen Expanding Vision Care Portfolio 56078 5...tho-McNeil Neurologics, a,division of Ortho-McNeil...at the U.S. Food and Drug Administration (FDA) has...iramate), based on studies submitted in,response t...use of TOPAMAX,in pediatric patients aged 1 to 24 ...to granting pediatric exclusivity, the FDA is cont...
...4 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) a...ase 3 clinical trial with AZ-004 (Staccato(R) loxa...eing developed for the treatment,of acute agitatio...er.,Alexza believes the novel, non-invasive nature...ng from inhaled loxapine administration via the,St...
Other Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |